See more : Loudspring Oyj (LOUD.HE) Income Statement Analysis – Financial Results
Complete financial analysis of Medicskin Holdings Limited (8307.HK) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Medicskin Holdings Limited, a leading company in the Medical – Care Facilities industry within the Healthcare sector.
- CHP Merger Corp. (CHPMU) Income Statement Analysis – Financial Results
- TradeUP Global Corporation (TUGC) Income Statement Analysis – Financial Results
- AutoZone, Inc. (0HJL.L) Income Statement Analysis – Financial Results
- Anghami Inc. (ANGHW) Income Statement Analysis – Financial Results
- Amerant Bancorp Inc. (AMTBB) Income Statement Analysis – Financial Results
Medicskin Holdings Limited (8307.HK)
About Medicskin Holdings Limited
Medicskin Holdings Limited, an investment holding company, provides medical skin care services primarily in Hong Kong. It operates Medicskin centers, which provides various medical skin care services for the treatment of skin diseases and problems, such as acne, pigmentation, rosacea, dermatitis, eczema, and warts, as well as improvement of appearance through skin rejuvenation, facial sculpturing, and body contouring treatments; and treatment of acne scars and enlarged pores, removal of undesirable naevi, and hair removal. The company also offers derma fillers and facial contouring, intense focused ultrasound and ultrasound, radio frequency, lasers and light sources, laser and RF energy, and other treatments; skincare products; and health management services. In addition, it provides preventive health care services, such as genetic tests, history and physical examination, laboratory tests, diagnostics and imaging, and body check services; men's face, skin, and body care services; and shingles and human papillomavirus vaccines. The company was founded in 2000 and is headquartered in Central, Hong Kong. Medicskin Holdings Limited is a subsidiary of Topline Worldwide Limited.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 49.14M | 45.54M | 49.15M | 41.71M | 48.05M | 51.45M | 57.79M | 62.06M | 60.07M | 66.74M | 65.04M | 51.61M |
| Cost of Revenue | 34.37M | 8.86M | 7.01M | 7.31M | 8.83M | 7.71M | 7.86M | 8.27M | 7.70M | 8.48M | 8.27M | 24.78M |
| Gross Profit | 14.77M | 36.68M | 42.14M | 34.40M | 39.22M | 43.74M | 49.93M | 53.79M | 52.38M | 58.26M | 56.78M | 26.82M |
| Gross Profit Ratio | 30.05% | 80.54% | 85.74% | 82.47% | 81.63% | 85.02% | 86.40% | 86.68% | 87.19% | 87.30% | 87.29% | 51.98% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 0.00 | 0.00 | 1.62M | 1.65M | 8.45M | 0.00 | 0.00 | 0.00 | 9.15M | 3.57M | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 151.00K | 1.96M | 4.92M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 48.00K | 211.00K | 56.00K | 1.77M | 3.62M | 13.37M | 15.63M | 15.38M | 13.41M | 9.15M | 3.57M | 3.53M |
| Other Expenses | 0.00 | -7.11M | -8.16M | -901.00K | -1.09M | -21.74M | -14.65M | -15.35M | -13.39M | 33.62M | 26.60M | 0.00 |
| Operating Expenses | 48.00K | 30.99M | 30.28M | 33.52M | 43.18M | 30.51M | 31.94M | 34.17M | 34.76M | 42.77M | 30.17M | 9.06M |
| Cost & Expenses | 34.42M | 39.86M | 37.29M | 40.84M | 52.01M | 38.22M | 39.80M | 42.44M | 42.45M | 51.25M | 38.43M | 33.85M |
| Interest Income | 658.00K | 497.00K | 446.00K | 608.00K | 869.00K | 328.00K | 129.00K | 81.00K | 225.00K | 64.00K | 0.00 | 321.00K |
| Interest Expense | 509.00K | 779.00K | 396.00K | 491.00K | 840.00K | 0.00 | 0.00 | 0.00 | 0.00 | 439.00K | 264.00K | 0.00 |
| Depreciation & Amortization | 9.39M | 9.33M | 9.73M | 9.81M | 10.45M | 4.27M | 4.18M | 3.06M | 2.02M | 2.45M | 2.33M | 1.99M |
| EBITDA | 6.78M | 6.40M | 14.55M | 11.62M | 5.98M | -4.46M | 22.17M | 22.69M | 19.63M | 17.48M | 23.65M | 19.75M |
| EBITDA Ratio | 13.79% | 15.44% | 29.35% | 26.04% | 12.14% | 34.82% | 38.36% | 36.54% | 9.53% | 27.03% | 44.31% | 38.26% |
| Operating Income | 0.00 | -2.26M | 3.68M | -2.31M | -5.05M | -6.97M | 17.99M | 19.62M | 17.62M | 15.49M | 26.61M | 17.76M |
| Operating Income Ratio | 0.00% | -4.96% | 7.48% | -5.54% | -10.50% | -13.54% | 31.14% | 31.62% | 29.33% | 23.21% | 40.91% | 34.42% |
| Total Other Income/Expenses | -3.12M | -8.72M | -7.44M | -13.70M | -182.00K | -13.18M | -14.47M | -15.25M | -13.94M | -9.61M | -9.26M | -321.00K |
| Income Before Tax | -3.12M | -3.03M | 4.42M | 1.31M | -5.31M | -8.73M | 3.53M | 4.37M | 3.68M | 5.88M | 17.35M | 17.44M |
| Income Before Tax Ratio | -6.36% | -6.66% | 9.00% | 3.15% | -11.06% | -16.96% | 6.10% | 7.04% | 6.12% | 8.82% | 26.68% | 33.79% |
| Income Tax Expense | -22.00K | -2.00K | 276.00K | -48.00K | 86.00K | 177.00K | 1.24M | 1.20M | 1.32M | 2.56M | 3.62M | 2.91M |
| Net Income | -3.05M | -2.98M | 3.92M | 953.00K | -3.24M | -5.48M | 2.53M | 3.17M | 2.35M | 3.33M | 13.74M | 14.53M |
| Net Income Ratio | -6.20% | -6.53% | 7.98% | 2.28% | -6.74% | -10.65% | 4.38% | 5.10% | 3.92% | 4.99% | 21.12% | 28.16% |
| EPS | -0.01 | -0.01 | 0.01 | 0.00 | -0.01 | -0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.04 | 0.04 |
| EPS Diluted | -0.01 | -0.01 | 0.01 | 0.00 | -0.01 | -0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.04 | 0.04 |
| Weighted Avg Shares Out | 396.74M | 396.74M | 396.74M | 421.22M | 485.74M | 483.27M | 480.40M | 434.82M | 400.00M | 352.51M | 333.33M | 333.33M |
| Weighted Avg Shares Out (Dil) | 396.74M | 396.74M | 396.74M | 421.22M | 485.74M | 483.27M | 480.40M | 435.08M | 400.00M | 352.51M | 333.33M | 333.33M |
Source: https://incomestatements.info
Category: Stock Reports